Damé Medarski’s Post

Top o' the Mornin' to Ya! 🍀 As we jump into another big week in #medtech, let's first run through a few highlights from last... MedTech Innovator kicked off their 2024 Pitch Event Road Tour in LA, an incredible opportunity for the #innovators and #entrepreneurs in our industry to pitch and potentially partner with the largest nonprofit accelerator in the world. Congratulations to all those that will move forward! Paul Grand Busy week for #surgicalrobotics as Intuitive won #FDA clearance for its next gen Davinci 5, their most advanced and integrated system yet, while SS Innovations announced its first #mitral valve replacement using their robot. CMR Surgical announced a first use case of their platform in #Sweden Supratim Bose Mark Slack Luke Hares Cosm Medical received clearance for its #pelvicfloor technology, making the first personalized pessary available Derek Sham #Diabetes was active this week as the International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) was held in Italy, Medtronic Diabetes, Dexcom, and Abbott all announcing positive progress. Centese made big strides in their their clinical trials for better #cardiacsurgery and #atrialfibrillation care Evan Luxon Randy Preston, while Abbott and Edwards Lifesciences continue their race in better #tavr technologies Autonomix Medical completed its first #RF #ablation trial to treat #pancreatic cancer pain, important mission Lori Bisson and team More buzz with #neuro as SetPoint Medical won an approval for the treatment of #MS, and Axonics, Inc. received a new #CEMark, and Sooma Medical raised $5.4 Mil for their depression #neuromodulation device Tuomas Neuvonen SafeGuard Surgical won a FDA Breakthrough nod for a #colorectal stent developed in #Tampa Fl Scott Kelley, MD Affluent Medical announced #FIH implant of their #urinaryincontinence device Sebastien Ladet, Ph.D. Finally, my favorite article of the week is interesting as the Total Product Lifecycle Advisory Program (TAP) within #FDA is new, and in particular helpful for innovation like #BCI technology and ONWARD Medical. This program requires Breakthrough Device Designation, and is assembled to provide earlier and more frequent engagement with company and agency, ideally streamlining the process. THANK YOU to all my newspartners LSI, MassDevice, MedTech Dive, FierceHealthcare, Sean Whooley, Tom Salemi, Chris Newmarker, Danielle Kirsh and friends everywhere who share stories. https://lnkd.in/e9WSbrYJ

Weekly #MedTech #News Summary (Dec 2–6, 2024) 💰 Funding Announcements 💵 ➡OSSIO: Closed a $27.6M funding round to further MedTech innovations. Brian Verrier ➡Inotec (makers of NATROX® Wound Care ) Secured $33M to expand oxygen-powered wound care solutions in the US. Craig Kennedy ➡Raidium: Raised nearly €16M for its radiological foundation model. Paul Herent, M.D., Msc ➡ PhotoniCare, Inc.: Announced the first close of $4.6M in an anticipated $9M Series B funding. Cary Vance ➡LAUXERA CAPITAL PARTNERS: Closed the first round of its Lauxera Growth II fund at €300M (US$316M), representing 75% of the target. Charles Cornevin 📃#RegulatoryApprovals 📄 ➡Field Medical: Received FDA breakthrough designation for its pulsed field ablation system. Steven Mickelsen ➡MatOrtho Ltd: Gained regulatory approval for ReCerf® Hip Resurfacing Arthroplasty. Duncan Wilson ➡Centerline Biomedical: Achieved FDA 510(k) clearance for its IOPS Guidewire Handle, a second-generation device enhancing 3D vascular navigation with reduced reliance on fluoroscopy.  Gulam Khan, Vikash Goel ➡Movano Health: FDA cleared its smart ring’s pulse oximetry feature. John Mastrototaro ➡Beyond Air®: Achieved CE mark approval for its LungFit PH system. - Michael Gaul ➡Neo Medical: Spine care platform fully approved under EU Medical Device Regulation. Vincent Lefauconnier ➡PixCell Medical Medical: Obtained EU IVDR certification for its complete blood count analyzer. Avishay Bransky 🏥 Clinical Trials and Studies 🩺 ➡ShiraTronics, Inc.: Initiated an FDA IDE study for its implantable neuromodulation device. Rob Binney ➡Nervonik, Inc.: Completed the first human study of its nerve stimulation technology for chronic pain. Aydin Babakhani ➡Orthocell Ltd: Finished FDA 510(k) study for its Remplir™ technology. Paul Anderson ➡Synova Life Sciences: Submitted a 510(k) application for eSTAR Synova to the FDA, focusing on regenerative medical devices. John Chi 季崇健 ➡LINDERA: Published a JMIR Aging study validating its AI-driven fall risk prediction system, using real-world data from over 600 seniors. Diana Heinrichs 🏢 Corporate Announcements 📢 ➡NeoPredics AG: Announced a rebrand from NeoPrediX to NeoPredics, aligning with its strategic vision in neonatal, maternal, and perinatal health analytics. Thorsten Waloschek It is great to see couple of European regulatory approvals this week, alongside major funding rounds, and advancements in clinical studies, which continues highlighting the growth in innovative solutions across the MedTech industry. Guided Solutions #executivesearch #fundraising #gscapitalconnect

⚡ ZAP Surgical Systems, Inc. secured $78m in a financing round led by and in partnership with Chinese healthcare company Qingdao Baheal Medical. The funding will further the manufacturing and distribution efforts of ZAP Surgical’s ZAP-X Gyroscopic Radiosurgery platform for non-invasive stereotactic radiosurgery procedures to treat brain tumours, lesions, and other conditions of the head and neck. 🚀 ZAP Surgical founder and CEO John Adler commented: “We founded ZAP Surgical to address a clear need: enabling more patients to access state-of-the-art radiosurgery without the prohibitive costs and infrastructure requirements that limit so many providers." 🔗 Read more: https://lnkd.in/dycy4iYY #MedicalDevice #MedTech #MedicalEquipment #HealthTech #SeriesA #MedicalDevices #Medicine #TechNews #Funding #MedTechFunding #FundingRound #AngelInvestment #GSCapitalConnect

🧬FluidAI Medical, a #SOPHIE recipient and postoperative medical technology company, recently invested $25 million in manufacturing its Origin™ medical device! 👉The team started their journey in 2014, with the goal to develop a postoperative monitoring solution to address post-surgery complications that can occur during recovery. “ Innovation Factory ’s Synapse Life Science Competition was actually a key moment for us. It was when we were going through a major pivot and a major transition in terms of product design,” added Abdelgawad. 🔬After pivoting and multiple iterations to their design, the team created what we now know as the Origin™, a non-invasive postoperative medical device that works in combination with the Stream™ Platform to analyze and accurately diagnose fluid samples. 🤝FluidAI's journey is a testament to how collaborations within the ecosystem can help set up entrepreneurs for success and growth in the sector. 💡How did FluidAI leverage the ecosystem and programs like SOPHIE and #HEALTHI to get to where they are today? Read the full story to find out! https://loom.ly/Xf3vzCQ ---------------------------------------------------------------------------------------- #MedTech #LifeSciences #Technology #Innovation #Ontario

Laborie Medical Technologies has completed its acquisition of Urotronic, the #medicaldevice company, as previously announced. According to TechSci Research, the acquisition of Urotronic by Laborie Medical Technologies is expected to be advantageous for both companies. Urotronic's innovative #medical technologies, including the Optilume drug-coated balloon #technology, complement Laborie's existing diagnostic and therapeutic solutions. This strategic diversification allows both companies to expand their product and service offerings, enhancing their competitiveness and market presence. Additionally, the acquisition is likely to lead to increased investments in research and development, which will support the creation of advanced medical devices and therapies.

🏥 𝐁𝐫𝐞𝐚𝐬𝐭 𝐋𝐞𝐬𝐢𝐨𝐧 𝐋𝐨𝐜𝐚𝐥𝐢𝐳𝐚𝐭𝐢𝐨𝐧 𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲 𝐨𝐧 𝐭𝐡𝐞 𝐑𝐢𝐬𝐞! 📈 Download PDF Brochure: https://lnkd.in/djexS6yB The global Breast Lesion Localization Market is set to make significant strides in medical technology: 🔹 Current Market Value: USD 0.3 Billion (2023) 🔹 Projected Market Value: USD 0.4 Billion (2028) 🔹 Compound Annual Growth Rate (CAGR): 6.9% Key Market Segments: • Localization Types: Wire, Radioisotope (ROLL, RSL), Magnetic, Electromagnetic • Primary Usage: Breast Biopsy, Lumpectomy • End Users: Hospitals, Diagnostic Imaging Centers, Ambulatory Surgical Centers This growth reflects advancing medical technologies, improved diagnostic capabilities, and increasing focus on early breast cancer detection and precise surgical interventions. The market expansion signals: - Enhanced medical imaging techniques - More precise surgical procedures - Improved patient outcomes 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞: Hologic, Inc., Becton, Dickinson and Company, Merit Medical Systems, Inc., Leica Biosystems, Argon Medical Devices, Inc. Other Companies that are Operating in this Market Globally: American Breast Care Hologic, Inc. RTI Surgical® Sientra, a Tiger Aesthetics Brand Mentor Worldwide LLC Shield HealthCare - Medical Supplies for Care at Home Since 1957 ImpediMed CQ Medical Formerly CIVCO Radiotherapy Mammotome Elucent Medical, Inc. Invivo Corporation UE LifeSciences CQ Medical Formerly Qfix KUBTEC Medical Imaging Merit Medical Oncology Molbio Diagnostics Altimate Medical GC Aesthetics Bard Davol SuperSonic Imagine Remington Medical Inc. IceCure Medical Dilon Technologies Inc. Brainlab Beekley Medical #MedicalTechnology #Healthcare #MarketTrends #BreastCancerAwareness #MedicalInnovation

𝑵𝒐𝒕𝒆𝒘𝒐𝒓𝒕𝒉𝒚 𝑴𝒆𝒅𝑻𝒆𝒄𝒉 𝑨𝒄𝒒𝒖𝒊𝒔𝒊𝒕𝒊𝒐𝒏𝒔 𝒊𝒏 𝒓𝒆𝒄𝒆𝒏𝒕 𝒎𝒐𝒏𝒕𝒉𝒔; 👀 It has been a while since my recent market update, As I primarily specialise in Medical Device roles across Europe I thought I could help provide an update with several significant changes in the industry... 🔬 Boston Scientific Acquires Silk Road Medical focused on Vascular Surgery and Stroke Prevention 🔬 Merit Medical has acquired Cook Medical’s lead management business for $210 million, predicted to produce $40m revenue for the American Device company 🔬 Siemens Healthineers Buys Novartis’ Radiopharmaceutical, Molecular PET Imaging Assets in Diagnostics 🔬 Stryker has acquired Vertos Medical, a company specializing in minimally invasive treatments for lumbar spinal stenosis 🔬 Cardiovascular Med Device company Getinge switches focus with the acquisition of Paragonix Technologies for safer Organ Transplantation with a deal valuing at $477 Million There seems to be a lot of volatility in the Medical Device space at the moment, if you are looking for any insight or advice then feel free to reach out! #ARTO 📞 +44 7401 093215 📧 [email protected]

Start-up LaNua Medical will use these funds to develop ‘Ecore’, an umbrella-shaped device which intends to modernise embolisation procedures, and expand in the US. The #seedfundinground was co-led by Elkstone and Atlantic Bridge, with participation from Enterprise Ireland and Furthr VC. 💬 "It will enable our team to hire additional skilled resources, develop a range of devices to meet the growing demands of embolisation in the interventional radiology medical community and gain entry into our first market in the US,” CEO Tom Fitzmaurice said of this funding round. 🔗 Read more: https://lnkd.in/dhxPcFxk #MedicalDevice #MedTech #MedicalEquipment #HealthTech #SeriesA #MedicalDevices #Medicine #TechNews #Funding #MedTechFunding #FundingRound #AngelInvestment #GSCapitalConnect

🔬 𝐀𝐦𝐧𝐢𝐨𝐭𝐢𝐜 𝐏𝐫𝐨𝐝𝐮𝐜𝐭𝐬 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐒𝐞𝐭 𝐟𝐨𝐫 𝐑𝐨𝐛𝐮𝐬𝐭 𝐆𝐫𝐨𝐰𝐭𝐡 Download PDF Brochure: https://lnkd.in/d2hwia3Q Exciting market developments in the biomedical sector! The global amniotic products market is poised for significant expansion, projected to reach USD 1.29 billion by 2028, up from USD 900 million in 2023 (CAGR: 7.4%). Key Market Segments: • By Type:  - Cryopreserved Amniotic Membranes  - Dehydrated Amniotic Membranes • Applications driving growth:  - Wound Care  - Ophthalmology  - Orthopedics Primary end users include hospitals and ambulatory surgical centers, highlighting the increasing adoption of these innovative biological materials in clinical settings. 💡 What's driving this growth? - Rising prevalence of chronic wounds - Increasing surgical procedures - Growing awareness of regenerative medicine - Technological advancements in tissue preservation MiMedx, Smith+Nephew (UK), Organogenesis Inc. (US), Integra LifeSciences, Stryker, APPLIED BIOLOGICS. (US), Celularity Inc. (US), Corza Ophthalmology (US), Lucina BioSciences, LLC, and Next Biosciences. (South Africa) Other Companies that are Operating in this Market Globally: Smiths Medical Symmetry Surgical Diagnostic Cardiology at Baxter - U.S. Moog Medical Cadwell Dexcom ICU Medical Skytron Delta Medical Systems Mortara Instrument CODAN US Corporation Getinge InfuSystem ScottCare Cardiovascular Solutions ReactDx SunTech Medispec SCHILLER USA SleepMed Incorporated Micrel Medical Devices Eitan Medical Micromed Merits Health Products, Inc. iRhythm Technologies International AWAK Technologies #HealthcareInnovation #BiomedicalScience #MarketGrowth #RegenerativeMedicine #Healthcare #MedicalTechnology #BiotechIndustry